Management of stroke in pregnancy and the puerperium

Expert Review of Neurotherapeutics

Volumn 10, Issue 2, 2010, Pages 205-215

  Tang, Sung Chun ^a   Jeng, Jiann Shing ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Cerebral venous thrombosis; Preeclampsia; Pregnancy; Puerperium; Stroke; Women

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

AFRICAN AMERICAN; AGE DISTRIBUTION; ANTICOAGULANT THERAPY; ANTIPHOSPHOLIPID SYNDROME; ARTERY THROMBOSIS; BLOOD CLOT LYSIS; BLOOD VESSEL RUPTURE; BRAIN ARTERIOVENOUS MALFORMATION; BRAIN ARTERY ANEURYSM; BRAIN VEIN; CEREBROVASCULAR MALFORMATION; CESAREAN SECTION; CLEFT PALATE; CONGENITAL MALFORMATION; DRUG SAFETY; ECLAMPSIA; EMBOLISM; EXOPHTHALMOS; FIBRINOLYTIC THERAPY; GASTROSCHISIS; HEART DISEASE; HUMAN; HYPERCOAGULABILITY; HYPERTENSION; INCIDENCE; INSULIN RESISTANCE; LIPID METABOLISM; LOW DRUG DOSE; MATERNAL MORTALITY; NEURAL TUBE DEFECT; PREECLAMPSIA; PREGNANCY; PREGNANT WOMAN; PROSTHETIC VALVE THROMBOSIS; PUERPERIUM; REVIEW; RISK BENEFIT ANALYSIS; RISK FACTOR; STROKE; SUBARACHNOID HEMORRHAGE; THROMBOPHILIA; VENOUS THROMBOEMBOLISM;

ANTICOAGULANTS; FEMALE; HUMANS; POSTPARTUM PERIOD; PREGNANCY; PREGNANCY COMPLICATIONS; PUERPERAL DISORDERS; RISK FACTORS; STROKE;

EID: 76249112504     PISSN: 14737175     EISSN: 17448360     Source Type: Journal    
DOI: 10.1586/ern.09.126     Document Type: Review

References (120)

1. Sibai BM, Coppage KH. Diagnosis and management of women with stroke during pregnancy/postpartum. Clin. Perinatol. 31, 853-868 (2004).
2. van Oppen ACC, van der Tweel I, Alsbach GPJ, Heethaar RM, Bruinse HW. A longitudinal study of maternal hemodynamics during normal pregnancy. Obstet. Gynecol. 88, 40-46 (1996).
3. Elkayam U. Pregnancy and cardiovascular disease. In: Braunwald's Heart Disease: a Textbook of Cardiovascular Medicine (Seventh Edition). Zipes DP, Libby P, Bonow RO, Braunwald E (Eds). Elsevier, PA, USA (2005).
4. Wilterdink JL, Easton JD. Cerebral ischemia in pregnancy. In: Neurological Complication of Pregnancy (Second Edition). Hainline B, Devinsky O (Eds). Lippincott Williams & Wilkins, PA, USA 51-62 (2002).
5. Treadwell SD, Thanvi B, Robinson TG. Stroke in pregnancy and the puerperium. Postgrad. Med. J. 84, 238-245 (2008).
6. Mas JL, Lamy C. Stroke in pregnancy and the puerperium. J. Neurol. 245, 1431-1459 (1998).
7. Bavie CA, O'Brien P. Stroke and pregnancy. J. Neurol. Neurosurg. Psychiatry 79, 240-245 (2008).
8. Simoke GA, Cox SM, Cunningham FG. Cerebrovascular accidents complicating pregnancy and the puerperium. Obstet. Gynecol. 78, 37-42 (1991).
9. De Swiet M. Maternal mortality: confidential enquiries into maternal deaths in the United Kingdom. Am. J. Obstet. Gynecol. 182, 760-766 (2000).
10. Chang J, Elam-Evans LD, Berg CJ et al. Pregnancy-related mortality surveillance - United States, 1991-1999. MMWR Surveill. Summ. 52, 1-8 (2003).
11. Neilson JP. Maternal mortality. Obstet. Gynecol. Reprod. Med. 19, 33-36 (2008).
12. Cross JN, Castro PO, Jennett WB. Cerebral strokes associated with pregnancy and the puerperium. Br. Med. J. 3, 214-218 (1968).
13. Wiebers DO, Whisnant JP. The incidence of stroke among pregnant women in Rochester Minn, 1955 through 1979. JAMA 254, 3055-3057 (1985).
14. Sharshar T, Lamy C, Mas JL. Incidence and causes of strokes associated with pregnancy and puerperium. A study in public hospitals of Ile de France. Stroke 26, 930-936 (1995).
15. Kittner SJ, Stern BJ, Feeser BR et al. Pregnancy and the risk of stroke. N. Engl. J. Med. 335, 768-774 (1996). • Excellent paper showing increased stroke risk in the puerperium but not during pregnancy.
16. Witlin AF, Friedman SA, Egerman RS, Frangieh AY, Sibai BM. Cerebrovascular disorders complicating pregnancy - beyond eclampsia. Am. J. Obstet. Gynecol. 176, 1139-1148 (1997).
17. Jaigobin C, Silver FL. Stroke and pregnancy. Stroke 31, 2948-2951 (2000).
18. Lanska DJ, Kryscio RJ. Risk factors for peripartum and postpartum stroke and intracranial venous thrombosis. Stroke 31, 1274-1282 (2000).
19. Skidmore FM, Williams LS, Fradkin KD, Alonso RJ, Biller J. Presentation, etiology, and outcome of stroke in pregnancy and puerperium. J. Stroke Cerebrovasc. Dis. 10, 1-10 (2001).
20. Ros HS, Lichtenstein P, Bellocco R et al. Increased risks of circulatory diseases in late pregnancy and puerperium. Epidemiology 12, 456-460 (2001). • Good data analysis from a Swedish cohort showing increased risk of circulatory diseases confined to a few days around delivery.
21. Jeng JS, Tang SC, Yip PK. Incidence and etiologies of stroke during pregnancy and puerperium as evidenced in Taiwanese women. Cerebrovasc. Dis. 18, 290-295 (2004).
22. James AH, Bushnell CD, Jamison MG, Myers ER. Incidence and risk factors for stroke in pregnancy and the puerperium. Obstet. Gynecol. 106, 509-516 (2005). • Excellent paper showing incidence and risk factors of pregnancy-related stroke from a large US nationwide in-patient sample.
23. Liang CC, Chang SD, Lai SL, Hsieh CC, Chueh HY, Lee TH. Stroke complicating pregnancy and the puerperium. Eur. J. Neurol. 13, 1256-1260 (2006).
24. Bateman BT, Schumacher HC, Bushnell CD et al. Intracerebral hemorrhage in pregnancy. Frequency, risk factors, and outcome. Neurology 67, 424-429 (2006).
25. Bashiri A, Lazer T, Burstein E et al. maternal and neonatal outcome following cerebrovascular accidents during pregnancy. J. Matern. Fetal. Neonatal. Med. 20, 241-247 (2007).
26. Lanska DJ, Kryscio RJ. Stroke and intracranial venous thrombosis during pregnancy and puerperium. Neurology 51, 1622-1628 (1998).
27. Cantu C, Barinagarrementeria F. Cerebral venous thrombosis associated with pregnancy and puerperium. Review of 67 cases. Stroke 24, 1880-1884 (1993).
28. Ros HS, Lichtenstein P, Bellocco R et al. Pulmonary embolism and stroke in relation to pregnancy: how can high-risk women be identified? Am. J. Obstet. Gynecol. 186, 198-203 (2002).
29. Lin SY, Hu CJ, Lin HC. Increased risk of stroke in patients who undergo Cesarean section delivery: a nationwide populationbased study. Am. J. Obstet. Gynecol. 198, 391.E1-E7 (2008).
30. Tihtonen K, Kööbi T, Yli-Hankala A, Uotila J. Maternal hemodynamics during Cesarean delivery assessed by whole-body impedance cardiography. Acta Obstet. Gynecol. Scand. 84, 355-361 (2005).
31. Kupferminc MJ, Yair D, Bornstein NM, Lessing JB, Eldor A. Transient focal neurological deficits during pregnancy in carriers of inherited thrombophilia. Stroke 31, 892-895 (2000).
32. Gerhardt A, Scharf RE, Beckmann MW et al. Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium. N. Engl. J. Med. 342, 374-380 (2000).
33. Lamy C, Hamon JB, Coste J et al. Ischemic stroke in young women. Risk of recurrence during subsequent pregnancies. Neurology 55, 269-274 (2000).
34. Jeng JS, Tang SC, Yip PK. Stroke in women of reproductive age: comparison between stroke related and unrelated to pregnancy. J. Neurol. Sci. 221, 25-29 (2004).
35. Redman CW, Sargent IL. Latest advances in understating preeclampsia. Science 308, 1592-1594 (2005).
36. World Health Organization International Collaborative Study of Hypertensive Disorder of Pregnancy. Geographic variation in the incidence of hypertension in pregnancy. Am. J. Obstet. Gynecol. 158, 80-83 (1988).
37. Duckitt K, Harrington D. Risk factors for preeclampsia at antenatal booking: systemic review of controlled studies. Br. Med. J. 330, 565-571 (2005).
38. Walsh SW. Obesity: a risk factor for preeclampsia. Trends Endocrinol. Metab. 18, 365-370 (2007).
39. Bainbridge SA, Roberts JM. Uric acid as a pathogenic factor in preeclampsia. Placenta 22, S67-S72 (2008).
40. McDonard SD, Mlinowski A, Zhou Q, Yusuf S, Devereaux PJ. Cardiovascular sequence of preeclampsia/eclampsis: a systematic review and meta-analysis. Am. Heart J. 156, 918-930 (2008).
41. Newstead J, von Dadelszen P, Magee LA. Preeclampsia and future cardiovascular risk. Expert Rev. Cardiovasc. Ther. 5, 283-294 (2007).
42. Irgens HU, Reisaeter L, Irgens LM, Lie RT. Long term mortality of mothers and fathers after preeclampsia: population based cohort study. Br. Med. J. 24, 1213-1217 (2001).
43. Smith GC, Pell JP, Walsh D. Pregnancy complications and maternal risk of ischaemic heart disease: a retrospective cohort study of 129,290 births. Lancet 357, 2002-2006 (2001).
44. Bellamy L, Casas JP, Hingorani AD, Williams DJ. Preeclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. Br. Med. J. 335, 974-977 (2007). • Excellent review of preeclampsia as the risk of cardiovascular disease in later life.
45. Kajantie E, Eriksson JG, Osmond C, Thornburg K, Barker DJ. Preeclampsia is associated with increased risk of stroke in the adult offspring: the Helsinki birth cohort study. Stroke 40, 1176-1180 (2009).
46. Hansen WF, Burnham SJ, Svendsen TP, Katz VL, Thorp JM Jr, Hansen AR. Transcranial Doppler findings of cerebral vasospasm in preeclampsia. J. Matern. Fetal Med. 5, 194-200 (1996).
47. Qureshi AI, Frankel MR, Ottenlips JR, Stern BJ. Cerebral hemodynamics in preeclampsia and eclampsia. Arch. Neurol. 53, 1226-1231 (1996).
48. Vliegen JH, Muskens E, Keunen RW, Smith SJ. Godfried WH, Gerretsen G. Abnormal cerebral hemodynamics in pregnancy-related hypertensive encephalopathy. Eur. J. Obstet. Gynecol. Reprod. Biol. 49, 198-200 (1993).
49. Williams K, Mclean C. Maternal cerebral vasospasm in eclampsia assessed by transcranial Doppler. Am. J. Perinatol. 10, 243-244 (1993).
50. Zeeman GG, Fleckenstein JL, Twickler DM, Cunningham FG. Cerebral infarction in eclampsia. Am. J. Obstet. Gynecol. 190, 714-720 (2004).
51. Coomarasamy A, Honest H, Papaioannou S et al. Aspirin for prevention of preeclampsia in women with historical risk factors: a systematic review. Obstet. Gynecol. 101, 1319-1332 (2003).
52. Euser AG, Cipolla MJ. Magnesium sulfate for the treatment of eclampsia: a brief review. Stroke 40, 1169-1175 (2009).
53. Lucas MJ, Leveno KJ, Cunningham FG. A comparison of magnesium sulfate with phenytoin for the prevention of eclampsia. N. Engl. J. Med. 333, 201-205 (1995).
54. The eclampsia trial collaborative group. Which anticonvulsant for women with eclampsia? Evidence from the collaborative eclampsia trial. Lancet 345, 1455-1463 (1995).
55. Naidu S, Payne AJ, Moodley J, Hoffmann M, Gouwe E. Randomized study assessing the effect of phenytoin and magnesium sulphate on maternal cerebral circulation in eclampsia using transcranial dopper ultrasound. Br. J. Obstet. Gynaecol. 103, 111-116 (1996).
56. Ringer AJ, Qureshi AI, Kim SH, Fessler RD, Guterman LR, Hopkins LN. Angioplasty for cerebral vasospasm from eclampsia. Surg. Neurol. 56, 373-378 (2001).
57. Brady K, Duff P. Rheumatic heart disease in pregnancy. Clin. Obstet. Gynecol. 32, 21-40 (1989).
58. Stout KK, Otto CM. Pregnancy in women with valvular heart disease. Heart 93, 552-558 (2007).
59. Sawhney H, Aggarwal N, Suri V et al. Maternal and perinatal outcome in rheumatic heart disease. Int. J. Gynecol. Obstet. 80, 9-14 (2003).
60. Van Mook WNKA, Peeters L. Severe cardiac disease in pregnancy, part II: impact of congenital and acquired cardiac diseases during pregnancy. Curr. Opin. Crit. Care 11, 435-448 (2005).
61. Siu SC, Sermer M, Colman JM et al. Prospective multicenter study of pregnancy outcomes in women with heart disease. Circulation 104, 515-521 (2001).
62. North RA, Sadler L, Stewart AW, McCowan LM, Kerr AR, White HD. Long-term survival and valve-related complications in young women with cardiac valve replacement. Circulation 99, 2669-2676 (1999).
63. Chan WS, Anand S, Ginsberg JS. Anticoagulation of pregnant women with mechanical heart valves. Arch. Intern. Med. 160, 191-196 (2000).
64. Abboud J, Murad Y, Chen-Scarabelli C, Saravolatz L, Scarabelli TM. Peripartum cardiomyopathy: a comprehensive review. Int. J. Cardiol. 118, 295-303 (2007).
65. Pearson GD, Veille JC, Rahimtoola S et al. Peripartum cardiomyopathy: National Heart, Lung, and Blood Institute and Office of Rare Diseases (National Institutes of Health) workshop recommendations and review. JAMA 283, 1183-1188 (2000).
66. Dyken ME, Biller J. Peripartum cardiomyopathy and stroke. Cerebrovasc. Dis. 4, 325-328 (1994).
67. Ford RF, Barton JR, O'Brien JM, Hollingsworth PW. Demographics, management, and outcome of peripartum cardiomyopathy in a community hospital. Am. J. Obstet. Gynecol. 182, 1036-1038 (2000).
68. Al-Shahi R, Bhattacharya JJ, Currie DG et al. Prospective, population-based detection of intracranial vascular malformations in adults: the Scottish Intracranial Vascular Malformation Study (SIVMS). Stroke 34, 1163-1169 (2003).
69. Stapf C, Labovitz DL, Sciacca RR, Mast H, Mohr JP, Sacco RL. Incidence of adult brain arteriovenous malformation hemorrhage in a prospective populationbased stroke survey. Cerebrovasc. Dis. 13, 43-46 (2002).
70. Al-Shahi R, Warlow C. A systematic review of the frequency and prognosis of arteriovenous malformations of the brain in adults. Brain 124, 1900-1926 (2001).
71. Choi JH, Mohr JP. Brain arteriovenous malformations in adults. Lancet Neurol. 4, 299-308 (2005).
72. Horton JC, Chambers WA, Lyons SL et al. Pregnancy and the risk of hemorrhage from cerebral arteriovenous malformations. Neurosurgery 27, 867-871 (1990).
73. Fujita K, Tsunoda H, Sghigemitsu S, Kubo T. [Clinical study of the intracranial arteriovenous malformation associated with pregnancy]. Nippon Sanka Fujinka Gakka Zasshi 47, 1359-1364 (1995).
74. Dias MS, Sekhar LN. Intracranial haemorrhage from aneurysms and arteriovenous malformations during pregnancy and the puerperium. Neurosurgery 27, 855-866 (1990).
75. Lanzino G, Jensen ME, Cappelletto B, Kassell NF. Arteriovenous malformations that rupture during pregnancy: a management dilemma. Acta Neurochir. 126, 102-106 (1994).
76. Trivedi RA, Kirkpatrick PJ. Arteriovenous malformations of the cerebral circulation that rupture in pregnancy. J. Obstet. Gynecol. 23, 484-489 (2003).
77. Selo-Ojeme DO, Marshman LA, Ikomi A et al. Aneurysmal subarachnoid haemorrhage in pregnancy. Eur. J. Obstet. Gynecol. Reprod. Biol. 116, 131-143 (2004).
78. Shah AK. Non-aneurysmal primary subarachnoid hemorrhage in pregnancyinduced hypertension and eclampsia. Neurology 61, 117-120 (2003).
79. Ursell MR, Marras CL, Farb R et al. Recurrent intracranial hemorrhage due to postpartum angiopathy: implications for management. Stroke 29, 1995-1998 (1998).
80. Arnold M, Camus-Jacqmin M, Stapf C et al. Postpartum cervicocephalic artery dissection. Stroke 39, 2377-2379 (2008).
81. Stoodley MA, Macdonald RL, Weir BK. Pregnancy and intracranial aneurysms. Neurosurg. Clin. N. Am. 9, 549-556 (1998).
82. Fox MW, Harms RW, Davis DH. Selected neurologic complications of pregnancy. Mayo Clin. Proc. 65, 1595-1618 (1990).
83. Barrett JM, Van Hooydonk JE, Boem FH. Pregnancy-related rupture of arterial aneyrysms. Obstet. Gynecol. Surv. 37, 557-566 (1982).
84. Tiel Groenestege AT, Rinkel GJ, van der Bom JG, Algra A, Klijn CJ. The risk of aneurysmal subarachnoid hemorrhage during pregnancy, delivery, and the puerperium in the utrecht population: case-crossover study and standardized incidence ratio estimation. Stroke 40, 1148-1151 (2009).
85. Roma H, Descargues G, Lopes M et al. Subarachnoid hemorrhage due to cerebral aneurysmal rupture during pregnancy. Acta Obstet. Gynecol. Scand. 83, 330-334 (2004).
86. Marshman LA, Aspoas AR, Rai MS, Chawda SJ. The implications of ISAT and ISUIA for the management of cerebral aneurysms during pregnancy. Neurosurg. Rev. 30, 177-180 (2007).
87. Williams TL, Lukovits TG, Harris BT, Rhodes CH. A fatal case of postpartum cerebral angiopathy with literature review. Arch. Gynecol. Obstet. 275, 67-77 (2007).
88. Calabrese LH, Dodick DW, Schwedt TJ, Singhal AB. Narrative review: reversible cerebral vasoconstriction syndromes. Ann. Intern. Med. 146, 34-44 (2007).
89. Singhal AB, Kimberly WT, Schaefer PW, Hedley-Whyte ET. Case 8-2009: a 36-year-old women with headache, hypertension, and seizure 2 weeks postpartum. N. Engl. J. Med. 360, 1126-1137 (2009).
90. Schievink WI. Spontaneous dissection of the carotid and vertebral arteries. N. Engl. J. Med. 344, 898-906 (2001).
91. Agostoni E, Aliprandi A, Longoni M. Cerebral venous thrombosis. Expert Rev. Neurother. 9, 553-564 (2009).
92. Bousser MG, Ferro J. Cerebral venous thrombosis: an update. Lancet Neurol. 6, 162-170 (2007).
93. Ferro JM, Canhão P, Stam J, Bousser MG, Barinagarrementeria F. Prognosis of cerebral veins and dural sinus thrombosis. Results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke 35, 664-670 (2004).
94. Bansal BC, Gupta RR, Prakash C. Stroke during pregnancy and puerperium in young females below the age of 40 years as a result of cerebral venous/venous sinus thrombosis. Jpn. Heart J. 21, 171-183 (1980).
95. Srinivasan K. Cerebral venous and arterial thrombosis in pregnancy and puerperium. A study of 135 patients. Angiology 34, 731-746 (1983).
96. Ferro JM, Canhão P. Complications of cerebral vein and sinus thrombosis. Front. Neurol. Neurosci. 23, 161-171 (2008).
97. Einhaupl K, Bousser MG, de Bruijn SF et al. EFNS guideline on the treatment of cerebral venous and sinus thrombosis. Eur. J. Neurol. 13, 553-559 (2006).
98. Rai R, Cohen H, Dave M, Regan L. Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). Br. Med. J. 314, 253-257 (1997).
99. Bates SM, Greer IA, Pabinger I, Sofaer S, Hirsh J. Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy. Chest 133, 844S-886S (2008). •• Excellent review of management of venous thromboembolism and thrombophilia, as well as the use of antithrombotic agents, during pregnancy.
100. Kozer E, Nikfar S, Costei A et al. Aspirin consumption during the first trimester of pregnancy and congenital anomalies: a meta-analysis. Am. J. Obstet. Gynecol. 187, 1623-1630 (2002).
101. Nørgård B, Puhó E, Czeizel AE, Skriver MV, Sørensen HT. Aspirin use during early pregnancy and the risk of congenital abnormalities: a population-based case-control study. Am. J. Obstet. Gynecol. 192, 922-923 (2005).
102. Sebastian C, Scherlag M, Kugelmass A, Schechter E. Primary stent implantation for acute myocardial infarction during pregnancy: use of abciximab, ticlopidine, and aspirin. Cathet. Cardiovasc. Diagn. 45, 275-279 (1998).
103. Wilson AM, Boyle AJ, Fox P. Management of ischaemic heart disease in women of child-bearing age. Intern. Med. J. 34, 694-697 (2004).
104. Boztosun B, Olcay A, Avci A, Kirma C. Treatment of acute myocardial infarction in pregnancy with coronary artery balloon angioplasty and stenting: use of tirofiban and clopidogrel. Int. J. Cardiol. 127, 413-416 (2008).
105. Helms AK, Drogan O, Kittner SJ. First trimester stroke prophylaxis in pregnant women with a history of stroke. Stroke 40, 1158-1161 (2009).
106. Gibson PS, Powrie R. Anticoagulants and pregnancy: when are they safe? Cleve. Clin. J. Med. 76, 113-127 (2009).
107. Sacco RL, Adams R, Albers G et al. Guidelines for prevention of stroke in patients with ischemic stroke or TIA. Stroke 37, 577-617 (2006).
108. Greer IA, Nelson-Piercy C. Low-molecularweight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy. Blood 106, 401-407 (2005). • Excellent review of low-molecular-weight heparins for thromboprophylaxis in pregnancy.
109. Warkentin TE, Levine MN, Hirsh J et al. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. N. Engl. J. Med. 332, 1330-1335 (1995).
110. Sanson BJ, Lensing AW, Prins MH et al. Safety of low-molecular-weight heparin in pregnancy: a systematic review. Thromb. Haemost. 81, 668-672 (1999).
111. Leonhardt G, Gaul C, Nietsch HH, Buerke M, Schleussner E. Thrombolytic therapy in pregnancy. J. Thromb. Thrombolysis 21, 271-276 (2006).
112. De Keyser J, Gdovinová Z, Uyttenboogaart M, Vroomen PC, Luijckx GJ. Intravenous Alteplase for stroke: beyond the guidelines and in particular clinical situations. Stroke 38, 2612-2618 (2007).
113. Dapprich M, Boessenecker W. Fibrinolysis with alteplase in a pregnant woman with stroke. Cerebrovasc. Dis. 13, 290 (2002).
114. Johnson DM, Kramer DC, Cohen E, Rochon M, Rosner M, Weinberger J. Thrombolytic therapy for acute stroke in late pregnancy with intra-arterial recombinant tissue plasminogen activator. Stroke 36, E53-E55 (2005).
115. Wiese KM, Talkad A, Mathews M, Wang D. Intravenous recombinant tissue plasminogen activator in a pregnant woman with cardioembolic stroke. Stroke 37, 2168-2169 (2006).
116. Méndez JC, Masjuán J, García N. Successful intra-arterial thrombolysis for acute ischemic stroke in the immediate postpartum period: case report. Cardiovasc. Intervent. Radiol. 31, 193-195 (2006).
117. Murugappan A, Coplin WM, Al-Sadat AN et al. Thrombolytic therapy of acute ischemic stroke during pregnancy. Neurology 66, 768-770 (2006).
118. Elford K, Leader A, Wee R et al. Stroke in ovarian hyperstimulation syndrome in early pregnancy treated with intra-arterial rt-PA. Neurology 59, 1270-1272 (2002).
119. Turrentine MA, Braems G, Ramirez MM. Use of thrombolytics for the treatment of thromboembolic disease during pregnancy. Obstet. Gynecol. Surg. 50, 534-541 (1995).
120. Aleu A, Mellado P, Lichy C, Köhrmann M, Schellinger PD. Hemorrhagic complications after off-label thrombolysis for ischemic stroke. Stroke 38, 417-422 (2007).